Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Gossamer Bio Inc (GOSS)  
$0.67 0.00 (-0.30%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 225,410,000
Market Cap: 150.57(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4783 - $1.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 8
Insider 3/6 Months : 8.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Co.'s clinical-stage product candidates include: Seralutinib, also known as GB002, which is an inhaled small molecule, platelet-derived growth factor receptor colony-stimulating factor 1 receptor and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, which is an oral small molecule for the treatment of inflammatory bowel disease; and GB5121, which an oral small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 232,000 232,000 1,400,505
Total Buy Value $0 $138,093 $138,093 $2,465,139
Total People Bought 0 2 2 5
Total Buy Transactions 0 2 2 12
Total Shares Sold 44,068 44,068 45,882 93,276
Total Sell Value $52,319 $52,319 $54,659 $345,585
Total People Sold 5 5 5 6
Total Sell Transactions 5 5 6 15
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 27
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Giraudo Bryan Chief Financial Officer   •       –      –    2020-10-14 4 B $10.01 $30,036 I/I 3,000 7,121 1.99 11%     
   Hasnain Faheem Director   –       •      –    2020-10-14 4 B $10.36 $999,995 I/I 96,520 3,478,629 2.1 11%     

  27 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed